3DBioNet IBIN – London, UK – 20 Jan 2020
Registration is now open for the Joint 3DBioNet IBIN Meeting taking place January 20th –...
read moreThe Electrospinning Company is a nanofibre innovation and development company that uses the electrospinning process to manufacture nanofibre structures and scaffolds for the biotech industry, and in particular the rapidly emerging stem cell therapy sector. Stem cells require optimum growing conditions both in labs and in humans and, uniquely, the Electrospinning Company is able to offer its customers both a better scaffold for laboratory use in the discovery phase of new stem cell therapies and also a route to then getting those therapies into patients by partnering with customers to develop specialized implantable nanofibre devices.
Status current
Associated Fund
GB EIS Fund,
UK Innovation & Science Seed Fund
Sector Medical / Biotechnology
Website www.electrospinning.co.uk/
Registration is now open for the Joint 3DBioNet IBIN Meeting taking place January 20th –...
read moreThe post World Biomaterials Congress – Glasgow, UK, 19-24th May 2020 appeared first on...
read moreCEO Ann Kramer will be speaking at the fourth annual biomaterials discovery workshop at...
read moreMeet our colleague and Mimetix-expert Stephen Jones at the 13th Drug Discovery ELRIG event...
read moreThe European patent office issued patent EP2812424 on 28th August 2019. The patented invention...
read moreMeet us at this year’s International College of Maxillofacial Surgery in Tel Aviv as...
read moreThe Electrospinning Company is the first investment from Midven's new GB EIS fund, through which…
read moreUpdate your browser to view this website correctly.Update my browser now